Stage FocusSeries A, Series B+
GeographyUS, Europe, China
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Ally Bridge Group was founded in 2013 by Frank Yu, operating from dual offices in New York and Hong Kong. The firm has led or co-led over $6B in transactions across healthcare subsectors, running a dual strategy: private equity (since 2013) and long-biased public equity (since 2018).
The focus is US, European, and Chinese healthcare markets at growth, late-stage, and buyout — positioning Ally Bri...
Notable Investments
W
WuXi AppTecG
GrailS
Shockwave MedicalI
Innovent BiologicsSimilar Funds
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedtechSeedSeries A
AstraZeneca Ventures
Cambridge, United Kingdom
GeneralistBiotechMedtechSeries ASeries B+
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedtechSeedSeries A
HV
HB Ventures
Shenzhen, China
DeepTech NativeBiotechSemiconductorsQuantumSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgritechMedtechSeedSeries A
Lilly Asia Ventures
Shanghai, China
DeepTech NativeBiotechMedtechSynthetic BiologySeries ASeries B+